2-42767674-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_012205.3(HAAO):āc.703G>Cā(p.Gly235Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00455 in 1,568,904 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0033 ( 1 hom., cov: 33)
Exomes š: 0.0047 ( 14 hom. )
Consequence
HAAO
NM_012205.3 missense
NM_012205.3 missense
Scores
3
9
5
Clinical Significance
Conservation
PhyloP100: 2.24
Genes affected
HAAO (HGNC:4796): (3-hydroxyanthranilate 3,4-dioxygenase) 3-Hydroxyanthranilate 3,4-dioxygenase is a monomeric cytosolic protein belonging to the family of intramolecular dioxygenases containing nonheme ferrous iron. It is widely distributed in peripheral organs, such as liver and kidney, and is also present in low amounts in the central nervous system. HAAO catalyzes the synthesis of quinolinic acid (QUIN) from 3-hydroxyanthranilic acid. QUIN is an excitotoxin whose toxicity is mediated by its ability to activate glutamate N-methyl-D-aspartate receptors. Increased cerebral levels of QUIN may participate in the pathogenesis of neurologic and inflammatory disorders. HAAO has been suggested to play a role in disorders associated with altered tissue levels of QUIN. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.020507514).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00327 (498/152312) while in subpopulation AMR AF= 0.00503 (77/15304). AF 95% confidence interval is 0.00428. There are 1 homozygotes in gnomad4. There are 200 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 14 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HAAO | NM_012205.3 | c.703G>C | p.Gly235Arg | missense_variant | 9/10 | ENST00000294973.11 | NP_036337.2 | |
HAAO | XM_011532729.4 | c.613G>C | p.Gly205Arg | missense_variant | 8/9 | XP_011531031.1 | ||
HAAO | XM_011532730.4 | c.601G>C | p.Gly201Arg | missense_variant | 10/11 | XP_011531032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HAAO | ENST00000294973.11 | c.703G>C | p.Gly235Arg | missense_variant | 9/10 | 1 | NM_012205.3 | ENSP00000294973.6 | ||
HAAO | ENST00000402698.6 | n.1047G>C | non_coding_transcript_exon_variant | 8/9 | 5 | |||||
HAAO | ENST00000404451.7 | n.644G>C | non_coding_transcript_exon_variant | 6/6 | 3 | |||||
HAAO | ENST00000406007.6 | n.254G>C | non_coding_transcript_exon_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00327 AC: 498AN: 152194Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
498
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00388 AC: 694AN: 178752Hom.: 4 AF XY: 0.00405 AC XY: 387AN XY: 95456
GnomAD3 exomes
AF:
AC:
694
AN:
178752
Hom.:
AF XY:
AC XY:
387
AN XY:
95456
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00469 AC: 6646AN: 1416592Hom.: 14 Cov.: 31 AF XY: 0.00461 AC XY: 3231AN XY: 700914
GnomAD4 exome
AF:
AC:
6646
AN:
1416592
Hom.:
Cov.:
31
AF XY:
AC XY:
3231
AN XY:
700914
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00327 AC: 498AN: 152312Hom.: 1 Cov.: 33 AF XY: 0.00269 AC XY: 200AN XY: 74472
GnomAD4 genome
AF:
AC:
498
AN:
152312
Hom.:
Cov.:
33
AF XY:
AC XY:
200
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
14
ALSPAC
AF:
AC:
18
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
47
ExAC
AF:
AC:
308
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | May 27, 2022 | - - |
HAAO-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 08, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Uncertain
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at